Administration of Anti-Tuberculosis Drugs through Patient Empowerment

Tropical Doctor

Volumn 27, Issue 4, 1997, Pages 240-

  Banerjee, A ^a   Salaniponi, F ^a   Harries, A ^a  

^a Ntcheu District Hospital   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALAWI; MALE; ORAL DRUG ADMINISTRATION; PATIENT MONITORING; TREATMENT OUTCOME;

ADULT; ANTITUBERCULAR AGENTS; CHI-SQUARE DISTRIBUTION; DRUG THERAPY, COMBINATION; FEMALE; HOSPITALS, DISTRICT; HUMANS; ISONIAZID; MALAWI; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT PARTICIPATION; RIFAMPIN; TUBERCULOSIS;

EID: 0030869699     PISSN: 00494755     EISSN: 17581133     Source Type: Journal    
DOI: 10.1177/004947559702700421     Document Type: Article

References (4)

1. Zent C, Smith P. Study of the effect of concomitant food on the bioavailability of rifampicin, isoniazid and pyrazinamide. Tuberc Lung Dis, 1995; 76: 109-13
2. World Health Organization. Treatment of Tuberculosis: Guidelines for National Programmes. Geneva: WHO, 1993
3. Weis SE, Slocum PC, Blais FX et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med, 1994; 330: 1179-84
4. Wilkinson D. High-compliance tuberculosis treatment programme in a rural community. Lancet, 1994; 343: 647-8